Endotoxemia induces an IL-6 response secondary to toll-like receptor binding, and elevated circulating IL-6 concentrations have been documented in experimentally induced endotoxemia in humans [79]. The gene discussed is IL6; the disease is serum lipopolysaccharide activity.